NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 645991 | Null | 0.000155853121040032 | 0.66814226 |
NSC 65628 | Null | 0.000155853121040032 | 0.51730379 |
NSC 658828 | Null | 0.000155853121040032 | 0.57912277 |
NSC 665104 | Null | 0.000155853121040032 | 0.4206626 |
NSC 673141 | Null | 0.000155853121040032 | 0.66380916 |
NSC 673267 | IL4(38-37)-PE38KDEL | 0.000155853121040032 | -0.29034135 |
NSC 67586 | 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, | 0.000155853121040032 | 0.37916328 |
NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.000155853121040032 | 0.40125665 |
NSC 753222 | 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline | 0.000177788864158557 | 0.37360235 |
NSC 135880 | Null | 0.000184748296800008 | 0.47545542 |